PGDx elio™ plasma resolve assay: targeted sequencing analyses of WBC DNA
The dataset "PGDx elio™ plasma resolve assay: targeted sequencing analyses of WBC DNA" includes paired end FASTQ reads of 49 white blood cell (WBC) genomic DNA samples from metastatic colorectal cancer patients. Sequencing was performed using a panel consisting of 33 genes, covering over 237,000 bp, targeting 25,000x depth across the targeted regions.
Data Access Policy of NKI-AvL TGO
To request access to this specific dataset, and in order to comply with local and (inter)national regulations, please follow the steps described below:
1. Please fill in the information requested on the website: ega.nki.nl
2. Once you’ve submitted this information, the Data Access Committee (DAC) and the NKI-AVL Internal Review Board (IRB) will review your planned study and its goals and judge whether it is competing with our interests. The DAC and IRB can approve or decline your request or request a modification.
3. Upon approval by the IRB, you will receive a Data Transfer Agreement (DTA) that needs to be filled in and signed by the legal representative of your institute / company.
4. Upon acceptance of a signed DTA by our Knowledge Transfer & Contracting Office (KT&C), your party will receive a copy signed by our legal representative, and you will need to submit your access request via the EGA website
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
No changes. Only the EGAS00001006695 study description text was changed.
Dataset Released
This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a
request.
If you already have access to these data files, please consult the
download documentation.